Evidence map›Paper›PMID 40240837›Full record

ArticleNature medicine2025

Meta-prediction of coronary artery disease risk.

Shang-Fu Chen, Sang Eun Lee, Hossein Javedani Sadaei, Jun-Bean Park, Ahmed Khattab, Jie-Fu Chen, Corneliu Henegar, Nathan E Wineinger, Evan D Muse, Ali Torkamani

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Shang-Fu ChenScripps Research Translational Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-5467-288X
Sang Eun LeeDepartment of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Hossein Javedani SadaeiScripps Research Translational Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-0848-9280
Jun-Bean ParkDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Ahmed KhattabScripps Research Translational Institute, La Jolla, CA, USA.
Jie-Fu ChenDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-4036-6969
Corneliu HenegarScripps Research Translational Institute, La Jolla, CA, USA.
Nathan E WineingerScripps Research Translational Institute, La Jolla, CA, USA.
Evan D MuseScripps Research Translational Institute, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-5288-7462
Ali TorkamaniScripps Research Translational Institute, La Jolla, CA, USA. atorkama@scripps.edu.ORCID http://orcid.org/0000-0003-0232-8053

Funding

Scripps Clinical and Translational Science HubUM1TR004407 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI Eric Jeffrey Topol · 2023 to 2026
$24.2M
Genotype First: Actionable Genetic Risk through Genotype-to-Phenotype PredictionR01HG010881 · NHGRI · SCRIPPS RESEARCH INSTITUTE, THE · PI TORKAMANI, ALI · 2020 to 2023
$3.1M
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) R01HG010881U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) UM1TR004407
6 · The paper itself

Abstract

Coronary artery disease (CAD) is a leading cause of morbidity and mortality worldwide, and accurately predicting individual risk is critical for prevention. Here we aimed to integrate unmodifiable risk factors, such as age and genetics, with modifiable risk factors, such as clinical and biometric measurements, into a meta-prediction framework that produces actionable and personalized risk estimates. In the initial development of the model, ~2,000 predictive features were considered, including demographic data, lifestyle factors, physical measurements, laboratory tests, medication usage, diagnoses and genetics. To power our meta-prediction approach, we stratified the UK Biobank into two primary cohorts: first, a prevalent CAD cohort used to train predictive models for cross-sectional prediction at baseline and prospective estimation of contributing risk factor levels and diagnoses (baseline models) and, second, an incident CAD cohort using, in part, these baseline models as meta-features to train a final CAD incident risk prediction model. The resultant 10-year incident CAD risk model, composed of 15 derived meta-features with multiple embedded polygenic risk scores, achieves an area under the curve of 0.84. In an independent test cohort from the All of Us research program, this model achieved an area under the curve of 0.81 for predicting 10-year incident CAD risk, outperforming standard clinical scores and previously developed integrative models. Moreover, this framework enables the generation of individualized risk reduction profiles by quantifying the potential impact of standard clinical interventions. Notably, genetic risk influences the extent to which these interventions reduce overall CAD risk, allowing for tailored prevention strategies.

Indexed as

Coronary Artery DiseaseAgedFemaleHumansMaleMiddle AgedRisk AssessmentRisk FactorsUnited Kingdom

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.